Ligand validation:4P8M

IMD: IMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4P8M_IMD_A_504	80%	73%	0.12	0.969	0.37	0.66	-	-	0	0	100%	1
4P8N_IMD_B_503	88%	76%	0.094	0.968	0.36	0.57	-	-	0	0	100%	1
4P8L_IMD_A_503	86%	81%	0.102	0.97	0.31	0.5	-	-	0	0	100%	1
4P8C_IMD_A_503	83%	77%	0.113	0.972	0.39	0.52	-	-	0	0	100%	1
4P8T_IMD_A_503	79%	75%	0.134	0.979	0.31	0.66	-	-	0	0	100%	1
4NCR_IMD_B_504	78%	67%	0.119	0.963	0.29	0.98	-	-	2	0	100%	1
4RS3_IMD_A_413	100%	61%	0.034	0.994	0.77	0.71	-	-	0	0	100%	1
6THT_IMD_A_301	100%	89%	0.036	0.993	0.6	0.05	-	-	0	0	100%	1
5OKB_IMD_B_502	100%	75%	0.036	0.984	0.38	0.58	-	-	1	0	100%	1
6IJ1_IMD_A_402	100%	52%	0.036	0.984	0.55	1.27	-	-	1	0	100%	1
3U9W_IMD_A_2009	100%	54%	0.038	0.985	0.43	1.32	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.